Additionally, epithelial-to-mesenchymal transition (EMT), a pivotal process in cancer leading to metastasis and drug resistance, necessitates PERK for the proliferation of EMT gene-expressing cells (Feng et al. 2014). The gene discussed is EIF2AK3; the disease is cancer.